
|Videos|April 5, 2022
Dr. Amy Paller discusses long-term safety and efficacy of ixekizumab in kids
Author(s)Miranda Hester
Dr. Paller discusses the findings of the clinical trial examining the long-term effects of ixekizumab for treating psoriasis in children.
Advertisement
Dr. Paller discusses the findings of the clinical trial discussing the long-term effects of ixekizumab for treating psoriasis in children.
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Health system–based clinical pathway improves pediatric lipid screening rates
2
FDA approves linaclotide (Linzess) for pediatric patients aged 7 years and older with IBS-C
3
Wesley Kufel, PharmD, discusses doxycycline for post-exposure prevention of Lyme disease in young children
4
Linaclotide demonstrates positive long-term safety
5













